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The cell cycle regulator GpsB functions as cytosolic
adaptor for multiple cell wall enzymes
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Bacterial growth and cell division requires precise spatiotemporal regulation of the synthesis
and remodelling of the peptidoglycan layer that surrounds the cytoplasmic membrane. GpsB
is a cytosolic protein that affects cell wall synthesis by binding cytoplasmic mini-domains of
peptidoglycan synthases to ensure their correct subcellular localisation. Here, we describe
critical structural features for the interaction of GpsB with peptidoglycan synthases from
three bacterial species (Bacillus subtilis, Listeria monocytogenes and Streptococcus pneumoniae)
and suggest their importance for cell wall growth and viability in L. monocytogenes and S.
pneumoniae. We use these structural motifs to identify novel partners of GpsB in B. subtilis and
extend the members of the GpsB interactome in all three bacterial species. Our results
support that GpsB functions as an adaptor protein that mediates the interaction between
membrane proteins, scaffolding proteins, signalling proteins and enzymes to generate larger
protein complexes at specific sites in a bacterial cell cycle-dependent manner.
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Peptidoglycan (PG), a network of glycan strands connectedby short peptides, forms the essential cell envelope thatmaintains cell shape and protects bacteria from osmotic
stresses1. High molecular weight (HMW) bi-functional penicillin
binding proteins (class A PBPs) are PG synthases that catalyse
glycan strand polymerisation and peptide crosslinking, whereas
HMW class B mono-functional PBPs only have transpeptidase
functions2. The PG layer needs remodelling to enable normal cell
growth and division and thus the bacterial cell cycle requires the
extracellular activities of PBPs3 and PG hydrolases4 to be co-
ordinated. The outer membrane-anchored LpoA/B lipoproteins
activate their cognate PBP1A/1B PG synthases in the synthesis of
the thin, periplasmic PG layer in the Gram-negative paradigm
Escherichia coli5,6. By contrast, Gram-positive bacteria have a
much thicker PG layer that is complemented with other anionic
cell wall polymers. PG synthesis regulation in Gram-positive
bacteria involves protein phosphorylation by orthologues of the
serine/threonine kinase PknB7/StkP8, and dedicated cell cycle
scaffolding proteins including DivIVA9, EzrA10 and GpsB11,12.
However, the molecular mechanisms that modulate PG synthesis
in Gram-positive bacteria are virtually unknown.
GpsB has emerged as a major regulator of PG biosynthesis in
low G+C Gram-positive bacteria, and its homologues (DivIVA/
Wag31/antigen 84) in Actinobacteria play essential roles in
hyphal growth and branching13–15. GpsB was initially char-
acterised in Bacillus subtilis where severe cell division and growth
defects were observed when both gpsB and ezrA11 or gpsB and
ftsA12 were deleted. Both EzrA and FtsA play roles in the
dynamics and membrane anchoring of the FtsZ Z-ring, the
constriction of which is fundamental to cell division16. The Z-ring
also recruits downstream proteins, including PBPs17,18, to com-
plete the process. Deletion of gpsB alone in Listeria mono-
cytogenes caused marked growth and division defects at 37 °C and
was lethal at 42 °C19. Moreover, gpsB deletion in L. mono-
cytogenes also resulted in enhanced susceptibility to β-lactam19
and fosfomycin20 antibiotics, reduced virulence in an insect
infection model19, and caused alterations to PG structure21.
Mutations in gpsB that affected binding to the PG synthase
PBPA1 also showed a lethal phenotype in L. monocytogenes at 42
°C19. The gpsB gene is essential in the Streptococcus pneumoniae
D39 progenitor strain as well as in some of its laboratory deri-
vatives and its inactivation resulted in elongated cells unable to
divide22–24. In addition, a genome-wide association study of S.
pneumoniae clinical isolates revealed that the presence of gpsB
variants was correlated significantly to β-lactam resistance25,
suggesting that GpsB may have fitness and pleiotropic roles in
maintaining cell wall integrity during antibiotic stress. The gpsB
gene has also been described as essential in the spherical bac-
terium Staphylococcus aureus, but the biochemical properties and
physiological functions of S. aureus GpsB in this recent report26
differ to what has been described in B. subtilis11,12,18,19,27 L.
monocytogenes19,27 and S. pneumoniae22–24.
In both B. subtilis11 and L. monocytogenes19, the cytosolic GpsB
localises to the lateral side walls of newborn, growing cells and to
the septum of dividing cells, the same localisation pattern as that
of B. subtilis PBP111. In S. pneumoniae, GpsB localises to mid-
cell22, the only region of active PG synthesis for both peripheral
(side-wall) elongation and cell division in this bacterium. The
localisation of GpsB at regions of active PG synthesis allows for
the interaction of GpsB with the poorly characterised cytoplasmic
mini-domains of PG synthases11,19,27,28. S. pneumoniae GpsB
(SpGpsB) has been found to co-immunoprecipitate with
SpPBP2a, SpPBP2b and SpMreC24, suggesting these proteins form
a complex that is regulated by SpGpsB24.
To gain molecular understanding of GpsB function, we report
three crystal structures of PBP cytoplasmic mini-domains in
complex with GpsB, the first structures of a PG synthase in
complex with a cytoplasmic cell cycle regulator. Despite a marked
absence of sequence and structural homology, we find that the
PBP domains interact with equivalent surfaces in GpsB using an
arginine that is conserved in the respective orthologues of the
PBPs. The visualisation of each complex permits a comprehensive
mutagenesis strategy and functional study to rationalise the role
of each interfacial amino acid in the PBP:GpsB pairs. We uncover
a sequence motif used by the B. subtilis PG synthase to interact
with GpsB. We identify two new members of the GpsB inter-
actome in this organism by querying the B. subtilis proteome with
this motif for potential new partners of GpsB, and provide evi-
dence for their connection to other, established proteins in
growth and division. We also identify extensive GpsB inter-
actomes in B. subtilis, L. monocytogenes and S. pneumoniae by
bacterial two-hybrid assays (BACTH). Therefore, the role of
GpsB in the bacterial cell cycle is that of an adaptor29–31, docking
PG synthases to other cell wall enzymes, scaffolds and shape
determinants into protein complexes for division (the divisome)
and peripheral growth (the elongasome).
Results
The first 16 residues of BsPBP1 dictate the BsGpsB interaction.
GpsB is an influential cell cycle regulator in low G+C Gram-
positive bacteria and we set out to establish the common rules by
which GpsB interacts with major PG synthases in three important
bacteria—one model species (B. subtilis) and two pathogens (L.
monocytogenes and S. pneumoniae). It has been determined
previously by us by SPR that the first 31 amino acids of the
cytoplasmic mini-domain of B. subtilis PBP1 (BsPBP1) were
critical for binding of BsGpsB19. Using the same technique the
binding site was further mapped to the first 16 amino acids of
BsPBP1 by comparing the interaction of BsGpsB with SPR chips
coated with full-length BsPBP1 and a PBP1 deletion mutant,
BsPBP117-914, where the codons for the first 16 amino acids were
removed genetically. While submicromolar concentrations of
BsGpsB bound to chips coated with the wild-type BsPBP1, there
was no interaction even when 25 µM BsGpsB was injected over
equivalent chips coated with BsPBP117-914 (Fig. 1a).
We subsequently solved the crystal structure of the complex
between the N-terminal domain of BsGpsB whose termini were
truncated slightly to expedite crystallisation, BsGpsB5-64, with the
first 17 amino acids of BsPBP1, BsPBP11-17 (Fig. 1b, c). The
BsPBP11-17 α-helix is stabilised by an intramolecular salt bridge
between BsPBP11-17Glu9 and BsPBP11-17Arg12 and by a hydrogen
bond between the sidechain of BsPBP11-17Ser7 and the backbone
amide of BsPBP11-17Ala10. A prominent feature of the complex is
the deep penetration of the sidechain of BsPBP1Arg8 into the
groove between BsGpsB5-64 α-helices 1 and 2, contacting the
mainchain carbonyl oxygens of BsGpsBIle13, BsGpsBLeu14 and
BsGpsBLys16 and forming a salt bridge with BsGpsBAsp31 (Fig. 1c),
which in turn is tethered in place by hydrogen bonds to the
hydroxyl of BsGpsBTyr25. The backbone amides of BsPBP1Arg8
and BsPBP1Glu9 interact with BsGpsBAsp35, mimicking the
mainchain interactions in successive turns in an α-helix. In a
longer α-helix, the backbone amides of BsPBP1Arg8 and
BsPBP1Glu9 would not be available to interact with BsGpsBAsp35
because of intra-helical hydrogen bonds with the mainchain
carbonyls of BsPBP1Phe5 and BsPBP1Asn6. The sidechain of
BsPBP1Arg11 forms hydrogen bonds with the carbonyl oxygen of
BsGpsBLeu14 and a salt bridge with BsGpsBGlu17. Van der Waals’
interactions connect BsPBP1Arg8 to BsGpsBLeu34 (Fig. 1c) and
BsPBP1Glu9 with BsGpsBLys32. The BsPBP11-17 peptide binds to a
groove between α-helices 1 and 2 in only one molecule of
BsGpsB5-64 in the crystallographic asymmetric unit as the second
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BsGpsB-binding site is blocked by crystal contacts. The key
interactions are mapped onto GpsB and PBP1 sequences in
Supplementary Figure 1A.
To rationalise the features of PBP cytoplasmic domains
important for determining recognition by GpsB, the interactions
described above were analysed further by fluorescence polarisation
(FP) and circular dichroism (CD). The BsGpsB1-68Glu17Ala,
BsGpsBTyr25Phe, BsGpsB1-68Asp31Ala and BsGpsB1-68Asp35Ala muta-
tions had little impact on protein stability (Supplementary
Figure 1B and Supplementary Note 1) and each reduced the
affinity for BsPBP11-32 by more than 8-fold (Supplementary
Figure 1C, Supplementary Table 1). BsPBP1Arg8Lys,
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Fig. 1 BsGpsB:BsPBP1 interactions require conserved arginines in the α-helical cytoplasmic minidomain of BsPBP1. a BsGpsB interacts with the first 16 amino
acids of BsPBP1. SPR sensorgrams of full-length BsGpsB against immobilised full-length BsPBP1 (black) and BsPBP117-914 (red). BsGpsB does not interact with
the BsPBP117-914 coated chip, even when 25 μM GpsB is injected. b Cartoon (left) and surface representation (right) of the crystal structure of the BsGpsB5-
64:BsPBP11-17 complex. BsGpsB5-64 is coloured cyan and BsPBP11-17 is coloured green and the likely plane of the bacterial membrane is shown as a red box.
c The BsGpsB5-64:BsPBP11-17 complex is dependent upon a conserved SRxxR(R/K) motif in BsPBP1. Key interfacial residues in the BsGpsB5-64:BsPBP11-17
complex are shown as sticks and coloured (and labelled) blue and green, respectively. The carbonyl oxygens of BsGpsBIle13, BsGpsBLeu14 and BsGpsBLys16
are labelled with their respective red numerals. Hydrogen bonds are shown as black dashed lines and the van der Waals’ interactions between BsGpsBLeu34
and BsPBP1Arg8 are in yellow. dMutation of key BsPBP1 interfacial residues in the structure of BsGpsB5-64:BsPBP11-17 leads to a loss of binding of position 16
TAMRA-labelled BsPBP11-32 variants to BsGpsB1-68 as measured by fluorescence polarisation. When the BsPBP11-32 peptide was labelled with fluorescein at
position 31 the measured affinity was the same as if the fluorophore was at position 16, indicating that the fluorophore itself or its position in the peptide
has no impact on the binding interaction. The calculated dissociation constants can be found in Supplementary Table 1
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BsPBP1Arg8Ala and BsPBP1Arg11Ala mutations each resulted in
reduced affinities for BsGpsB1-68 by at least 5-fold (Fig. 1d,
Supplementary Table 1). BsPBP11-32Arg28Ala had no effect on
binding (Fig. 1d, Supplementary Table 1), suggesting that the
overall positive charge of the peptide is not the primary
determinant of BsGpsB:BsPBP1 interactions, rather the unique
physicochemical characteristics of an arginine at position 8 in
BsPBP1 is essential. The BsPBP11-32Ser7Ala and BsPBP11-32Ala10Pro
mutations each reduced the affinity for BsGpsB1-68 by at least 6-
fold by affecting the α-helix of BsPBP11-32 (Fig. 1d, Supplemen-
tary Figure 1D, Supplementary Table 1 and Supplementary
Note 1), and the reduction in affinity was the same irrespective of
the position of the fluorophore in the peptide (Supplementary
Figure 1E, Supplementary Table 1). BsPBP11-32Ser7 acts as the
helix N-cap, a role that is performed preferentially by Ser, Asn
and Thr32, and alanine and proline substitutions in helical
positions equivalent to BsPBP11-32Ser7 and BsPBP11-32Ala10,
respectively, destabilise model peptides32,33. Finally, the impor-
tance of BsPBP11-32Ser7, BsPBP11-32Arg8 and BsPBP11-32Arg11 to
GpsB binding is highlighted because these are the most well
conserved residues in an alignment of the cytoplasmic mini-
domains of Bacillaceae PBP1 PG synthases (Supplementary
Figure 1F).
L. monocytogenes GpsB interacts with PBPA1 by a TRxxYR
motif. The deletion of gpsB alone in B. subtilis has no readily
apparent phenotype until combined with deletions in ezrA11 or
ftsA12; by contrast, the deletion of gpsB in L. monocytogenes is
lethal when grown at 42 °C19. Since GpsB in both species interact
with class A PG synthases, we next determined whether the rules
established above for the BsGpsB:BsPBP1 interaction could be
applied directly to LmGpsB:LmPBPA1. The cytoplasmic mini-
domain of LmPBPA1, LmPBPA11-29, has an abundance of posi-
tively charged residues, but lacks an exact copy of the SRxxR(R/K)
motif of Bacillaceae PBP1 (Supplementary Figure 1F, 2A); the
closest equivalent is TRxxYR. In FP, the first 20 amino acids of
LmPBPA1, LmPBPA11-20, bound to the N-terminal domain
of LmGpsB, LmGpsB1-73, with an affinity similar to that of
BsPBPA11-32 for BsGpsB1-68 (Supplementary Figure 2B, Supple-
mentary Table 1), but we were unable to co-crystallise LmGpsB
constructs with LmPBPA1 peptides to visualise these interactions
and to compare them to BsGpsB5-64:BsPBP11-17. Consequently,
and to expedite crystallisation, we solved the structure of the
first 15 amino acids of LmPBPA1, LmPBPA11-15, bound to
BsGpsB5-64Lys32Glu, which is a surrogate for LmGpsB1-73 because
(i) all the residues within 8 Å of the BsGpsB5-64:BsPBP11-17
interface are conserved in LmGpsB except for Lys32, which is
glutamate in LmGpsB, and thus all peptide-contacting residues are
maintained—as well as bystander residues that help indirectly to
shape the PBP binding site; (ii) LmGpsB and BsGpsB use over-
lapping PBP binding sites19; (iii) the Kds of BsGpsB1-68Lys32Glu
and LmGpsB1-73 for the first 20 amino acids of LmPBPA1,
LmPBPA11-20, are almost identical (Supplementary Figure 2B,
Supplementary Table 1). Therefore, the K32E variant of the
N-terminal domain of BsGpsB is as close a surrogate for the
equivalent LmGpsB domain that could be obtained.
The subsequent structure of the BsGpsB5-64Lys32Glu:LmPBPA11-15
complex revealed that, in contrast to the BsGpsB5-64:BsPBP11-17
complex, the majority of the LmPBPA1 peptide was disordered
except for LmPBPA11-15Arg8 and the immediately-adjacent main-
chain atoms. LmPBPA11-15Arg8 adopts the same orientation and
makes the same interactions as described above for BsPBP11-17Arg8
in the BsGpsB5-64:BsPBP11-17 complex (Figs. 1c, 2a). The bidentate
interaction of Glu35 of BsGpsB5-64Lys32Glu with the backbone amides
of LmPBPA1Arg8 and LmPBPA1Ser9 are maintained just as in the
BsGpsB5-64:BsPBP11-17 complex and, as the backbone torsion angles
of LmPBPA11-15Arg8 are also α-helical, it suggests that the role of the
conserved LmPBPA1Thr7 is to N-cap this helix32. The interaction of
BsGpsB5-64Lys32Glu with LmPBPA11-15 seemingly centres almost
entirely on a single arginine. How LmGpsB discerns LmPBPA1Arg8
over other positively charged residues in the arginine- and lysine-
rich cytoplasmic domain of LmPBPA1 (Supplementary Figure 2A)
was determined by FP and BACTH. LmPBPA11-20Arg8Ala and
LmPBPA11-20Arg12Ala mutations reduced the affinity for BsGpsB1-
68
Lys32Glu by >15- and ~4-fold, respectively (Supplementary
Figure 2B, Supplementary Table 1), and had significant negative
impact on the LmGpsB:LmPBPA1 interaction by BACTH (Fig. 2b).
Alanine substitution of LmPBPA1Tyr11 had a comparatively milder
impact in BACTH (Fig. 2b) and in FP (Supplementary Figure 2B,
Supplementary Table 1). Reintroducing positive charge into
LmPBPA11-20Arg8Ala did not restore wild-type binding affinity in
FP as LmPBPA11-20Arg8Ala,Ser16Arg still bound to BsGpsB1-68Lys32Glu
with an affinity at least 10-fold weaker than wild-type (Supplemen-
tary Figure 2B, Supplementary Table 1). BACTH also supports the
central importance of LmPBPA1Thr7, which presumably plays a
structural role in the LmPBPA11-15 peptide possibly by acting as an
N-cap and positioning LmPBPA1Arg8 at the start of an α-helix at the.
Alanine substitution of the other positively charged residues
downstream of residue 14 had no impact in BACTH (Fig. 2b),
consistent with the particularly stringent specificity of LmGpsB for
LmPBPA1Arg8 in comparison to other positively charged residues.
LmPBPA1Arg8 and BsPBP1Arg8 are equivalent in their inter-
actions with GpsB. Of the other GpsB-binding determinants of
BsPBP1, LmPBPA1 lacks an analogous BsPBP1Arg11. The
sequential equivalent is LmPBPA1Tyr11, but this residue is
completely disordered and its mutation to alanine reduced the
affinity for BsGpsB1-68Lys32Glu only by 2-fold (Supplementary
Figure 2B). To further decipher the reason for the specificity for
LmPBPA1Arg8, the importance of α-helix formation in
LmPBPA11-15 for GpsB binding was analysed with Q10P-
mutated LmPBPA1 peptides. A Q10P mutation caused a >7-fold
reduction in binding affinity (Supplementary Figure 2B, Supple-
mentary Table 1) and CD confirmed a significant impact of the
Q10P mutation on the α-helicity of LmPBPA11-15 peptides
(Supplementary Figure 2C). Finally, the effects of mutations to
the crucial LmGpsB-interacting residues in LmPBPA1 were also
probed in Listeria using fosfomycin sensitivity as a reporter since
ΔgpsB mutants are more susceptible to this antibiotic at 37 °C
than wild-type L. monocytogenes20. Fosfomycin inhibits the first
enzyme in the biosynthetic pathway of PG, MurA, and the ΔgpsB
mutant is hypersensitive to it probably because of unproductive
consumption of PG precursors due to mis-regulated LmPBPA120.
By contrast, removal of pbpA1 reduces substrate turnover in PG
biosynthesis and thus the cells become more resistant to
fosfomycin, and a pbpA1 pbpA2 double mutant is not viable34.
Effects on fosfomycin sensitivity were apparent in mutants
carrying the pbpA1Arg8Ala,Arg12Ala and pbpA1Gln10Pro alleles but
only when LmPBPA2, the LmPBPA1 paralogue, was also absent
(Fig. 2c). Synthetic lethality with pbpA2 and a growth defect at
42 °C is characteristic of the L. monocytogenes null gpsB mutant19,
suggesting that the observed effects partially phenocopy ΔgpsB.
However, no pbpA1 mutation phenocopied the ΔgpsB mutant
completely (Supplementary Figure 2D).
Taken together, our data highlight the importance of a
conserved arginine and α-helicity in class A PG synthases for
interacting with GpsB in two species. In both cases the arginine is
adjacent to a conserved residue with high propensity to act as a
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-018-08056-2
4 NATURE COMMUNICATIONS |          (2019) 10:261 | https://doi.org/10.1038/s41467-018-08056-2 | www.nature.com/naturecommunications
helix N-cap, implying that positioning of the arginine at the start
of the helix is critical. Furthermore, since pbpA1 does not
phenocopy gpsB in L. monocytogenes, and gpsB deletion on its
own in B. subtilis has no clear phenotype, GpsB must have
additional functions in both bacteria.
Extending the B. subtilis and L. monocytogenes GpsB inter-
actomes. The data presented above describe features critical for
interactions involving BsGpsB, which include a helical SRxxR(R/
K) motif in close proximity to the membrane. To identify hitherto
unidentified BsGpsB-interacting proteins, the B. subtilis proteome
was queried with the SRxxR(R/K) motif. Two previously
uncharacterised ORFs, BsYpbE and BsYrrS, conform to all the
features described above. BsYpbE is a membrane protein with a
56-residue cytoplasmic domain that encodes a SRVERR motif.
The extracellular region, residues 80–240, contains a LysM (lysin
motif) domain between residues 189 and 235; LysM domains are
~40-residue, degenerate PG- and chitin-binding modules wide-
spread in bacteria and eukaryotes. yrrS is found in a bicistronic
operon widely conserved in the Bacillaceae with the gene (yrrR)
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standard deviations are shown. Asterisks indicate statistically significant differences (P < 0.01, t-test)
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encoding a class B PBP, PBP4b35, suggesting these genes have a
linked function in cell wall homoeostasis36. BsYrrS comprises an
18-residue cytoplasmic domain with two potential, overlapping
BsGpsB-binding motifs SRYENR and NRDKRR and an extra-
cellular domain that belongs to the widespread and currently
uncharacterised DUF1510 family.
LysM domains are frequently found as tandem repeats within
bacterial proteins37 and the individual domains can act co-
operatively to bind PG38,39. BsYpbE contains one LysM domain
hence oligomerization of BsYpbE may enhance PG binding, with
the oligomerisation of the extracellular LysM domain of BsYpbE
presumably controlled by cytoplasmic, hexameric BsGpsB27, the
essential form of the protein in bacteria19. In the absence of
purified, full-length BsYpbE to test this hypothesis directly,
monomeric and dimeric forms of BsYpbE130-240, which encom-
passes the sole extracellular LysM domain, were generated instead.
Dimeric BsYpbE130-240 was prepared by mutation of Ser132 to
cysteine to enable disulphide-linked BsYpbE130-240Ser132Cys
dimers to be purified. In pulldown assays, the binding of
BsYpbE130-240Ser132Cys dimers to PG was enhanced considerably
relative to the monomeric, cysteine-free version of BsYpbE130-240
(Supplementary Figure 3A). Therefore, the binding of YpbE to PG
in B. subtilis will be stimulated by YpbE multimerisation, induced
by hexameric GpsB.
The interaction of BsGpsB1-68 with BsYrrS and BsYpbE was
assessed by FP and BACTH. BsGpsB1-68 bound to a 21-residue
fragment of the cytoplasmic domain of BsYpbE, BsYpbE1-21 that
encompasses the SRVERR motif, and the entire cytoplasmic
mini-domain of BsYrrS, BsYrrS1-18, with Kd values of 13 μM
(Fig. 3a) and 430 μM (Fig. 3b), respectively. The modest affinity
of the BsYrrS1-18 peptide for BsGpsB1-68 (Supplementary Table 1)
probably translates to a substantially tighter affinity in bacterial
cells, because of an avidity effect resulting from BsGpsB and
BsYrrS associating with membranes, effectively increasing the
local concentration of each significantly. The specificity of these
interactions measured by FP was consistent with the impact of
BsGpsBAsp31Ala and BsGpsBTyr25Phe mutations, each of which
reduced the affinities for BsYrrS1-18 and BsYpbE1-21 by 7- and
~40-fold, respectively (Fig. 3a, b), and in-line with the roles of
BsGpsBAsp31 and BsGpsBTyr25 in defining the BsPBP1 binding
site. Interactions of BsGpsB with BsYrrS and BsYpbE were also
detected by BACTH, with the interactions mapping to the N-
terminal domain of BsGpsB in both cases (Fig. 3c). GpsB is only
conditionally essential in B. subtilis11,12, and perhaps it is not
surprising that no obvious cell growth or division phenotypes
were identified in our hands or previously40 on deleting the genes
encoding BsYrrS, BsPBP4b or BsYpbE. BACTH was used to
confirm that BsYrrS interacted with BsPBP4b, BsPBP1 and
BsRodZ; the latter two proteins have established roles in cell
division, growth and morphogenesis41,42. The interaction
between BsPBP1 and a fragment of BsYrrS lacking residues 13-
16, BsYrrSΔ13-16 (which reduced non-specific binding to the
BsPBP1-immobilised SPR chip and did not affect the SRYENR
motif) was quantified by SPR, and BsYrrS Δ13-16 bound to BsPBP1
with a Kd of 20 nM (Supplementary Figure 3B). Therefore, these
gene products are capable of forming a network of interactions
(Fig. 3d) that may be nucleated by the formation of a BsPBP1:
BsYrrS complex.
Homologues of YpbE do not exist in L. monocytogenes and the
YrrS homologue (Lmo1495) does not contain a signature
BsGpsB-binding motif and neither protein is found in S.
pneumoniae. No strong potential GpsB-interacting candidates
were identified when the L. monocytogenes proteome was
searched with either TRxxYR or SRxxR(R/K) as the query.
BACTH was thus used to uncover additional potential LmGpsB
functions in L. monocytogenes using a bank of 27 listerial
components from the known elongation and division machineries
in bacteria (Supplementary Note 2). Twelve proteins were shown
to interact with LmGpsB and only these are shown in
Supplementary Figure 3C. There is no consensus motif shared
by these proteins, though all have at least one arginine present in
their cytoplasmic regions that is conserved in their respective
orthologues. Two classes of hits were identified in the BACTH
screen; class I hits (LmPBPA1, LmMreC and LmSepF, and
LmGpsB self-interactions) turned blue after one day of incubation
(Supplementary Figure 3C). Class II hits turned blue after 2 days
incubation at 30 °C, including LmZapA, LmEzrA, LmDivIB,
LmDivIC, LmMreC, LmMreBH and the other HMW LmPBPs
(Supplementary Figure 3C). All of these interactions, except for
the GpsB self-interactions, required the LmGpsB N-terminal
domain (Supplementary Figure 3C). In good agreement with the
absence of a TRxxYR motif in LmMreC, LmSepF and LmZapA,
interactions with these proteins did not require key residues in
the known PBP-binding groove in LmGpsB (Supplementary
Figure 3D) and reciprocal tests validated the LmGpsB:LmPBPA1
interactions21. It would thus seem that LmPBPA1 represents the
only GpsB binding partner that employs the TRxxYR motif in L.
monocytogenes.
Two arginines dictate S. pneumoniae GpsB:PBP2a molecular
recognition. S. pneumoniae, more distantly related to either
Bacillus or Listeria, is an ovoid-shaped Gram-positive coccus in
which GpsB is essential22–24. SpGpsB co-immunoprecipitated
with SpPBP2a (one of three pneumococcal class A PBPs),
SpMreC and other proteins, suggesting they interact at some
point in the pneumococcal cell cycle24. Synthetic lethality studies
in pneumococcal ΔgpsB suppressor mutants revealed that pbp1a,
and not pbp2a, became essential in the absence of gpsB indicating
that SpPBP2a is the class A PBP regulated by SpGpsB in S.
pneumoniae24. We found that the cytoplasmic mini-domain of
SpPBP2a and many of its orthologues contain the consensus
sequence (S/R)RS(R/G)(K/S)xR (Supplementary Figure 4A) that
resembles the Bacillaceae PBP1 SRxxR(R/K) motif (Supplemen-
tary Figure 1F). A 22-residue peptide of SpPBP2a that encom-
passes this region, SpPBP2a23-45, was found by FP to bind to the
N-terminal domain of SpGpsB, SpGpsB1-63, with a Kd of 80 μM
whereas SpGpsB1-63Asp33Ala (equivalent to BsGpsBAsp35Ala) had a
~40-fold reduced affinity for SpPBP2a23-45 (Fig. 4a, Supplemen-
tary Table 1). The crystal structure of a slightly truncated form of
the N-terminal domain of SpGpsB, SpGpsB4-63 (to expedite
crystallisation), was solved in the presence of a 14-residue peptide
of SpPBP2a, SpPBP2a27-40, which includes the (S/R)RS(R/G)(K/S)
xR motif. In this instance, each subunit of the SpGpsB dimer is
peptide-bound (Fig. 4b). Peptide binding principally involves two
arginines but each SpGpsB subunit recognises the peptide dif-
ferently. In SpGpsB4-63 molecule 1, SpPBP2a27-40 recognition
centres on SpPBP2aArg31 and SpPBP2aArg36 (Fig. 4c), whereas
molecule 2 involves SpPBP2aArg33 and SpPBP2aArg36 (Fig. 4d).
The arginine pairs occupy the same positions as BsPBP1Arg11 and
BsPBP1Arg8 in the BsGpsB5-64:BsPBP11-17 complex (Fig. 1c);
SpPBP2aArg36 is equivalent to BsPBP1Arg11whereas SpPBP2aArg31
and SpPBP2aArg33 are equivalent to BsPBP1Arg8.
The SpGpsB:SpPBP2a interaction was confirmed by BACTH
(Supplementary Figure 4B). The interaction was lost completely
with SpGpsBTyr23Ala, SpGpsBVal28Ala, SpGpsBAsp29Ala,
SpGpsBLeu32Ala and SpGpsBAsp33Ala mutated proteins and
reduced with SpGpsBIle36Ala (Fig. 5a). All the SpGpsB variants
retained the ability to self-interact and to interact with wild-type
SpGpsB (Fig. 5a, Supplementary Figure 4C); the impact of the
mutations on interactions with SpPBP2a thus does not reflect
impaired expression of the relevant fusion proteins. Moreover, all
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the SpGpsB variants, except SpGpsBAsp29Ala, retained some ability
to interact with SpMreC, which was also confirmed to interact
with SpGpsB by BACTH (Fig. 5a, Supplementary Figure 4B).
Despite differences in the secondary structures of the two
independent SpPBP2a peptides bound to the SpGpsB4-63 dimer
(Fig. 4b), the two arginines form a similar network of interactions
with SpGpsB as described for BsGpsB and LmGpsB (Figs. 1c, 2a)
with additional sidechain contacts in molecule 1 between
SpPBP2aSer32 and SpGpsBAsp33 (Fig. 4c), and SpPBP2aArg31 and
SpGpsBTyr23. The importance of SpPBP2aArg31 and SpPBP2aArg33
is further supported by their sequence conservation
(Supplementary Figure 4A) and FP (Fig. 4a, Supplementary
Table 1). Although SpPBP2aArg31Lys had only a 2-fold reduced
affinity, which probably reflects the ability of SpPBP2aArg33 to
compensate for the loss of SpPBP2aArg31, the binding affinity of
SpPBP2aArg31Lys,Arg33Lys was reduced >25-fold relative to wild
type. The importance of the SpGpsB residues involved in the
interactions with SpPBP2a is also consistent with the phenotype
because of the severe growth (Fig. 5b) and morphological defects
(Fig. 5c) of S. pneumoniae strains harbouring the SpGpsBTyr23Ala,
SpGpsBVal28Ala, SpGpsBAsp29Ala, SpGpsBLeu32Ala and SpGpsBAs-
p33Ala alleles even though the mutated proteins were still capable
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of self-interactions (Supplementary Figure 4C) and were
expressed at wild-type levels (Supplementary Figure 4D). Howe-
ver, no obvious phenotype was observed in S. pneumoniae strains
carrying the corresponding SpPBP2aArg31Ala, SpPBP2aArg33Ala or
SpPBP2aArg31Ala,Ser32Ala,Arg36Ala alleles, even when pbp1a was
deleted to decouple the effects of mutations in SpPBP2a from
SpPBP1a activity (Supplementary Table 2). Nevertheless,
SpPBP2a mutants in which amino acids 32–37 or 27–38 or
26–45 were deleted in a Δpbp1a background showed progres-
sively reduced growth rates in the three deletion strains and
pronounced morphological defects in the two strains with larger
deletions (Supplementary Figure 5A, 5B), despite wild-type levels
of protein expression at the respective expected molecular masses
(Supplementary Figure 5C). At least eight residues, including two
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arginines and one lysine, were retained in all the deletion
constructs before the predicted start of the SpPBP2a TM helix
(residue 54), providing the necessary charge to satisfy the inside-
positive rule43. Consistent with the pbp2a deletion mutant
phenotypes, BACTH results for the correspondent truncated
SpPBP2a variants showed reduced interactions with SpGpsB in
comparison to the wildtype but not with SpMreC (Supplementary
Figure 5D, 5E).
Together, these results support a critical role of the (S/R)RS(R/
G)(K/S)xR motif between SpPBP2a residues 30 and 36 for
mediating protein–protein interactions with SpGpsB and the
importance of its reduction or loss in S. pneumoniae. However,
the observation that all three Δpbp1a pbp2a deletion mutants
were viable and both growth and morphology phenotypes were
different between S. pneumoniae Δpbp1a strains depleted for gpsB
(Fig. 5d) and Δpbp1a strains depleted for pbp2a (Fig. 5e) implies
that SpPBP2a binding is also just one function for SpGpsB. It is
possible that the SpPBP2a:GpsB interaction is only part of the S.
pneumoniae ΔgpsB phenotype and this interaction per se is not
essential, unless the interaction of GpsB with an additional
partner is also lost. Alternatively, since deleting the GpsB binding
motif of SpPBP2a did not abolish the interaction with GpsB
completely, the deletion might reveal, or even generate, an
unpredicted GpsB binding site, perhaps in the juxta-membrane
region untouched by the deletions.
Since the pbp2a mutant did not phenocopy gpsB depletion, and
given the complex network of GpsB interactions in B. subtilis and
L. monocytogenes, we also sought to extend the pneumococcal
GpsB interactome starting from those proteins that were reported
to form a complex with SpGpsB by co-immunoprecipitation (co-
IP)24. Besides the SpGpsB interactions detected with SpPBP2a
and SpMreC by BACTH, we also detected an interaction between
SpGpsB and the essential class B SpPBP2x44 (Supplementary
Figure 6A). SpPBP2x, which contains a cytoplasmic domain
abundant with arginines, also interacted with SpGpsB in FP
experiments (Supplementary Figure 6B). However, a SpGpsB:
SpPBP2x interaction was not detected by co-IP either using
SpGpsB-L-FLAG3 as the bait and an anti-HA antibody to detect
HA-tagged SpPBP2x24 or an anti-SpPBP2x for native SpPBP2x
immnodetection, or SpPBP2x-FLAG3 as bait and an anti-SpGpsB
antibody for immunodetection of SpGpsB (Supplementary
Figure 6C). These results suggest that SpGpsB:SpPBP2x com-
plexes may be insufficiently abundant, or present only transiently,
to be detected by co-IP in pneumococcal cells. SpGpsB also
interacted in BACTH with the class A SpPBP1a (Supplementary
Figure 6A), which contains a LRLIKY motif in a putative helical
region in its small cytoplasmic domain of 18 amino acids. On the
other hand, no direct interaction was detected between SpGpsB
and SpPBP2b either by BACTH (Supplementary Figure 6A) or by
FP (Supplementary Figure 6B), consistent with the lack of any
candidate GpsB-binding sequence motif in SpPBP2b. The
SpPBP2b:SpGpsB interaction detected previously by co-IP24
(Supplementary Figure 6C) is therefore likely to be indirect,
presumably involving a bridging protein. The SpGpsBAsp33Ala
allele that resulted in a complete loss of binding to SpPBP2a by FP
(Supplementary Table 1) also abrogated interactions in BACTH
with a markedly greater impact on interactions with
SpPBP2a compared to SpMreC (Supplementary Figure 6A).
SpGpsBTyr23Ala and SpGpsBAsp29Ala mutations had a greater
impact on SpMreC interactions than SpGpsBAsp33Ala; this pattern
mirrors the impact of the equivalent mutations (LmGpsBTyr27Ala,
LmGpsBAsp33Ala and LmGpsBAsp37Ala) on MreC interactions in
L. monocytogenes (Supplementary Figure 3D) and thus sub-
stantiates the evidence that different surfaces are used by GpsB to
bind a specific class A PBP and MreC. Whilst the interactions of
SpGpsB with SpEzrA and SpStkP were confirmed by BACTH, and
observed with the reciprocal hybrid pairs, they were unaffected by
any of the SpGpsB alleles mentioned above (Supplementary
Figure 6A). The interactions of GpsB in the pneumococcus, as
detected by BACTH, FP and co-IP, are summarised in
Supplementary Figure 6D.
Taken as a whole, our data on three important bacterial
systems agree that GpsB is an adaptor protein29–31 that connects
a major class A PG synthase with other cell wall and cell cycle
proteins, and to cell shape determinants such as MreC. The
identity and mode of interaction of the GpsB-binding partners
varies from species to species and may reflect the different
physiologies of each bacterium and their modes of growth and
division.
Discussion
Bacterial cell growth and division necessitates tight co-ordination
between the replication and segregation of the chromosome, the
fission of the cell membrane and the remodelling of the PG.
Consequently proteins and their complexes with major functions
on either side of the membrane must co-ordinate their activities.
One potential mechanism involves the interactions of major PG
synthases with their intracellular regulators. Herein we present
the first structures of the cell cycle adaptor, GpsB, in complex
with the cytoplasmic mini-domains of PG synthases from three
different bacteria, the rod-shaped B. subtilis and L. mono-
cytogenes, in which gpsB is conditionally essential11,12,19 and the
ovococcal S. pneumoniae in which gpsB is essential22–24. In
common with mammalian adaptors GGA31 and 14-3-345 pro-
teins, the primary binding surface of GpsB is restricted to a
conserved groove between α-helices The cytoplasmic mini-
domains of the three PG synthases in the three organisms have
little in common except that each utilises a conserved arginine in
their respective sequences to interact with the cognate GpsB. The
PG synthase arginine finger pokes into a negatively charged cavity
Fig. 5 Depletion of SpPBP2a does not phenocopy depletion of SpGpsB. a Mutations in SpGpsB differentially affect interactions with SpPBP2a and SpMreC.
BACTH analysis of the interactions of SpGpsB-T18 variants with wild-type SpGpsB, SpPBP2a and SpMreC. pKT25/pUT18C and pKT25-zip/pUT18C-zip
plasmid pairs were used as negative (−ve) and positive (+ve) controls, respectively. The agar plates were photographed after 40h incubation at 30 °C. b, c
SpGpsB variants that have lost SpPBP2a binding have a gpsB null growth and morphology phenotype. Representative growth curve of S. pneumoniae strains
with ectopic expression of gpsB+ under a Zn2+-dependent promoter. GpsB variants of Y23A, V28A, L32A and D33A showed a gpsB null growth phenotype
(b) and elongated cell morphology (c) on gpsB depletion. The D29A variant showed an intermediate growth phenotype, which was also obtained with an
independent isogenic isolate and with a gpsBD29A-FLAG labelled strain. The I36A strain has a reduced elongation phenotype. All phase‐contrast
micrographs are at the same magnification (scale bar= 1 µm). d, e SpPBP2a depletion does not phenocopy SpGpsB. Representative growth curves (d) and
phase-contrast micrographs (e) of parent IU1824 (WT, D39 Δcps rpsL1), IU13444 (Δpbp1a), IU14381 (Δpbp2a//ΔbgaA::PZn-pbp2a+ Δpbp1a) and IU14383
(ΔgpsB//ΔbgaA::PZn-gpsB+ Δpbp1a). Similar to the depletion of SpGpsB in S. pneumoniae pbp1a+ strains (see panel b), depletion of SpGpsB in IU14383 leads
to extremely elongated cells, a growth cessation and lysis phenotype. By contrast, depletion of SpPBP2a in the Δpbp1a background (right hand panels) leads
to small but mostly ovococcal cells that do not lyse during the time course examined. All phase-contrast micrographs were taken at OD620≈ 0.15 or at the
time point marked by arrows in a for IU14381 and IU14383 under zinc depletion and are at the same magnification (scale bar= 1 µm)
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situated between α-helices 1 and 2 of GpsB and is fixed in the
same orientation in all structures, just as the phosphoryl group
defines the binding orientation of peptides to 14-3-345. The
arginine complements the cavity best when the mainchain amide
protons of it and its downstream residue are accessible to form
hydrogen bonds with BsGpsBAsp35, LmGspBAsp37 or
SpGspBAsp33. This scenario can occur when the arginine is either
at the start of an α-helix, such as BsPBP1Arg8, or at the i+ 1
position in a type I β turn, such as SpPBP2aArg31, which explains
why free L-arginine does not displace pre-bound PBP peptides
from GpsB even when present at 100-fold molar excess (Sup-
plementary Figure 2E). Similarly, contact to the backbone amide
at the i+ 2 position in 14-3-3 ligands is essential for binding45.
Despite a lack of strong sequence and structural homology in the
PG synthase cytoplasmic mini-domains, their binding is depen-
dent upon an identical subset of GpsB residues including
BsGpsBTyr25, BsGpsBAsp31, BsGpsBAsp35 (Fig. 1c) and their
structural equivalents LmGspBTyr27, LmGspBAsp33, LmGspBAsp37
(Fig. 2a), and SpGpsBTyr23, SpGpsBAsp29 and SpGspBAsp33
(Fig. 4c, d, Supplementary Figure 1A). Mutations at these posi-
tions in GpsB from S. pneumoniae and L. monocytgenes are lethal
or have marked growth defects (Fig. 5b, c)19 and do not interact
with their cognate peptidoglycan synthase by FP (Supplementary
Table 1)19 or by BACTH (Fig. 5a)19. A phenotype analysis of
equivalent mutations in B. subtilis to assess their importance is
not straightforward to determine for two reasons. First, a phe-
notype for the gpsB null mutant is only observed synthetically,
when gpsB is mutated alongside either ftsA12 or ezrA11. Second, a
B. subtilis mutant lacking all class A PBPs is viable46, precluding
an unequivocal assessment of the precise importance of the
BsGpsB:BsPBP1 interaction. Nonetheless, the convergence of all
our experimental data on three bacterial systems suggests strongly
that the tyrosine and aspartate dyad also have important roles in
B. subtilis. Furthermore, these amino acids are also conserved in
the DivIVA/Wag31/antigen 84 actinobacterial homologues of
GpsB, suggesting a role for them in recruiting cell wall synthesis
enzymes to the hyphal tip and future branch sites13,14, regions
that require nascent PG synthesis in filamentous bacteria.
We originally set out to establish the common rules by which
GpsB interacts with major PG synthases. Other than the arginine
finger mode of GpsB recognition, we discovered how GpsB
interacts with at least one class A PBP in each species; that
LmGpsB interacts with both the cell shape determinant, MreC47,
and a regulator of Z-ring dynamics, EzrA10, while in S. pneu-
moniae we have confirmed the SpGpsB:MreC interaction and
newly identified interactions with the class A SpPBP1a and with
the essential class B SpPBP2x44. These new data complement
what was previously known about these interactions in B. sub-
tilis11 and S. pneumoniae23,24. How GpsB can interact with such
disparate targets remains unknown but BsGpsBAsp31,
LmGpsBAsp33 and SpGpsBAsp29 are important for interactions
with PBPs and other proteins, including MreC, while
LmGpsBAsp37 and SpGpsBAsp33 only interact with PBPs. There
must be at least one other surface that is used by GpsB to form
complexes with other proteins in its function as an adaptor.
The GpsB:PBP interaction interface notably requires no more
than three sidechains from any PBP to complex with GpsB.
Protein:peptide contacts involving less well-conserved exosites
that flank a small core, conserved peptide motif can contribute
significantly to the affinity of protein:peptide interactions48,49,
and the contribution of exosites to affinity, such as the juxta-
membrane region, may explain why point mutations in
LmPBPA1 and SpPBP2a have a significant impact using peptide
fragments in vitro, but have reduced impact in bacterial cells. For
instance, the LmPBPA1Arg8Ala mutation had negligible effect (-
Fig. 2c, Supplementary Figure 2D) yet it reduced binding by > 15-
fold (Supplementary Table 1). Similarly SpPBP2aArg31Lys,Arg33Lys
had a > 25-fold impact on binding (Supplementary Table 1) yet
growth phenotypes were not evident (Supplementary Table 2)
until significant stretches of the cytoplasmic mini-domain were
deleted (Supplementary Figure 5B).
We also found some differences in GpsB interactions between
the species that may be related to GpsB species-specific function.
In B. subtilis, we discovered a critical motif, SRxxR(R/K), found in
close proximity to the membrane that could be used to predict
novel GpsB partners. We used this information to identify an
interaction network involving cell envelope binding and mod-
ifying proteins that most likely is underpinned by the GpsB
hexamer. An RSxxxR motif was identified in class A PBPs from
most streptococci and sequence features that could dictate GpsB-
binding can be found in class A PBPs in other Gram-positive
organisms such as the lactococci, Leuconostocaceae and enter-
ococci, including the ESKAPE pathogen E. faecium (Supple-
mentary Figure 7). However, sequence-based searches alone will
not identify complete GpsB interactomes because the local
structure of the sequence and its proximity to the membrane are
also key parameters of GpsB binding. SpPBP2a contains a par-
tially conserved sequence RSxxxR (Supplementary Figure 4A)
that resembles the BsPBP1 signature motif and the SpPBP2a
mini-domain interacts with each subunit of the SpGpsB dimer in
a different way (Fig. 4b–d). We have observed here that mutation
or deletion of the cytoplasmic mini-domain of SpPBP2a does not
phenocopy deletion or depletion of gpsB (Fig. 5c, e). Similarly, a
ΔpbpA1 strain did not phenocopy gpsB deletion in L. mono-
cytogenes19. Taken together these results imply that there must be
at least one other critical GpsB interaction partner, beyond
respective class A PG synthases, that dictates its conditional
essentiality in L. monocytogenes and B. subtilis, and essentiality
under normal growth conditions in S. pneumoniae.
In every Firmicute (and Actinobacterium) tested thus far, apart
from S. aureus26, GpsB (or the homologous DivIVA/Wag31/
antigen 84) acts as an adaptor to co-ordinate PG synthase activity
with other processes depending on the physiology of the cell.
GpsB hexamerisation can bridge the interaction of multiple
binding partners, a function GpsB shares with 14-3-3 proteins
that can form ternary complexes with BCR and Raf-1 by 14-3-3
dimerisation50. In bacilli, BsGpsB plays a role in shuttling
between the side wall during elongation and the septum during
division11 and, given that BsPBP4b is regulated by σ factors E[35]
and F[51], complexes of BsPBP4b and BsYrrS, bridged by BsGpsB
(Fig. 3c, d), presumably play a role in the asymmetric cell division
characteristic of endospore-forming bacilli. In listeria, which is
closely related to bacilli and shares with them a rod-like mor-
phology, GpsB appears to connect several PBPs with proteins
with known roles in cytokinesis, including Z-ring polymerisation
modulators (ZapA, EzrA, SepF), late division proteins (DivIB,
DivIC) and the elongasome (MreC, MreBH) (Supplementary
Figure 3C,D), all of which except SepF and MreBH have also been
tested in B. subtilis and found not to interact with BsGpsB11. By
contrast, S. aureus GpsB appears to modulate Z-ring assembly26,
however, no interaction between FtsZ and GpsB has been iden-
tified in B. subtilis11, S. pneumoniae23,24 or L. monocytogenes
(Supplementary Figure 3C).
The pneumococci have an ovoid cell shape and lack key
components such as the MinCD system for cell division site
selection52, and MreB-like proteins required for side wall synth-
esis53. Presumably SpGpsB interacts with one or more
pneumococcal-specific proteins, the loss of which may be related
to the lethal phenotype. Furthermore, SpGpsB affects both StkP
autophosphorylation23,24 and the StkP-catalysed phosphorylation
of SpDivIVA23,24, SpMapZ/LocZ24,54, SpJag/EloR/KhpB55–57 and
SpMacP58. It is not yet clear how the complexes formed by these
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proteins are affected by their phosphorylation, except that
SpPBP2a activity is dependent upon phosphorylated SpMacP58, at
least in the presence of functional SpStkP, or what the impact is of
potential cross-talk to two-component signalling systems59.
Finally, the different phenotypic outcomes associated with gpsB
deletion or depletion in the three systems studied herein may
reflect the presence of redundant systems in the large genome (4.2
Mbp) of the bacilli, partial redundancy in listeria (2.9 Mbp), and a
relative absence of redundancy in the stripped-down genome (2.1
Mbp) of the pneumococci. The relative affinities and cellular
concentrations of GpsB partners probably dictate which protein
(s) is bound by GpsB at any point in a cell cycle-dependent
manner; simultaneous interactions with multiple target proteins
is likely to lead to an increase in avidity of GpsB19 as commonly
found in antibody:antigen interactions. However, the intricate
networks involving GpsB will only be uncovered by validating the
full GpsB interactome.
Methods
Bacterial strains and growth conditions. Supplementary Table 3 lists the bac-
terial strains used in this study. L. monocytogenes EGD-e-derived strains were
routinely cultivated in brain heart infusion (BHI) broth or on BHI agar plates at
37 °C or 42 °C, where indicated. If required, erythromycin (5 µg−1mL−1) and
X-Gal (40–100 µg−1mL−1) were added. All L. monocytogenes growth experiments
were repeated three times and average values and standard deviations are shown.
All S. pneumoniae strains were derived from unencapsulated serotype 2 D39 strains
IU1824 (D39 Δcps rpsL1) or IU1945 (D39 Δcps)60. S. pneumoniae strains were
grown on Petri dishes containing the appropriate antibiotic, modified trypticase soy
agar II (Becton-Dickinson) and 5% (vol per vol) defibrinated sheep blood (TSAII-
BA), and the plates were incubated at 37 °C in 5% CO2. Bacteria were cultured
statically in BHI (Becton-Dickinson) broth at 37 °C in an atmosphere of 5% CO2,
and growth was monitored by OD620. Escherichia coli TOP10 and DH5α (lab
stocks) were used as standard hosts for all cloning procedures61, and BL21(DE3)
strains (lab stocks) were used for recombinant protein production.
General methods, manipulation of DNA and oligonucleotide primers. E. coli
transformation and isolation of plasmid DNA (the plasmids used are listed in
Supplementary Table 4) was performed according to standard protocols61. L.
monocytogenes strains were transformed by electroporation. Enzymatic modifica-
tion of plasmid DNA was carried out as described by the instructions given by the
manufacturers. Quikchange mutagenesis was employed for restriction-free mod-
ification of plasmids62. DNA sequences of oligonucleotide primers are listed in
Supplementary Tables 5–7. All deletions and insertions were confirmed by PCR,
and all constructs and clones were verified by Sanger DNA sequencing.
Construction of L. monocytogenes mutant strains. Plasmid pSH497 was first
constructed to facilitate mutagenesis of the chromosomal copy of pbpA1. A DNA
fragment comprising recU and the first 2063 bp of pbpA1 was amplified from
chromosomal DNA using primer pair SHW773/SHW774 and cloned into pMAD
using BamHI/NcoI. An unwanted mutation in front of recU resulted in a correction
of this plasmid by Quikchange with primer pair SHW777/SHW778. The corrected
pSH497 was used as template in further Quikchange reactions to introduce
Thr7Ala (SHW744/SHW745, pSH504), Arg8Ala (SHW746/SHW747, pSH505),
Tyr11Ala (SHW755/SHW756, pSH506), Gln10Pro (SHW787/SHW788, pSH509)
and Arg12Ala mutations (SHW748/SHW749, pSH507) into pbpA1, or to remove
pbpA1 nucleotides 4-1250 (SHW775/SHW776, pSH503). pSH508 (pbpA1Arg8Ala/
Arg12Ala) was obtained by Quikchange with primers SHW750/SHW751 and plas-
mid pSH505 as the template. An N-terminal fragment of pbpA1 was excised from
the L. monocytogenes chromosome using plasmid pSH503 and the insertion/
excision protocol for construction of clean deletions, resulting in strain LMS211.
The mutated pbpA1 alleles present on pSH504-pSH509 were then reintroduced
into LMS211 following the same protocol.
L. monocytogenes fosfomycin susceptibility assays. Fosfomycin susceptibility
was recorded using filter discs (Ø 6 mm) soaked with 10 µL of a 10 mg−1mL−1
fosfomycin solution. L. monocytogenes colonies, grown on BHI agar plates, were
resuspended in BHI broth and used to swab-inoculate BHI agar plates. Filter discs
soaked with fosfomycin were placed on top of the agar surface and the plates were
incubated at 37 °C overnight. Diameter of growth inhibition zones was measured
and corrected for the filter disc diameter. All experiments were performed three
times and average values and standard deviations were calculated. Significance was
determined using the t-test and differences were considered to be significant when
P < 0.01.
L. monocytogenes and B. subtilis BACTH assay. The BACTH system63 was used
for analysis of protein:protein interactions. First, LmGpsB was screened against
LmPBPA1 (lmo1892) variants to identify residues in LmPBPA1 that are important
for binding LmGpsB. To facilitate screening, we used a T25 fragment of Bordetella
pertussis adenylate cyclase that had been fused to the N-terminal 91 amino acids of
LmPBPA1 to create a T25-LmPBPA1 fusion containing the N-terminal cyto-
plasmic mini-domain and the transmembrane helix, but lacking lacking the
extracellular glycosyltransferase and transpeptidase domains (T25-PBPA1ΔGT-
TP) in plasmid pSH43721. LmPBPA1 residues that corresponded to the BsGpsB
binding motif of BsPBP1 (Thr7, Arg8, Tyr11, Arg12) and additional positively
charged amino acids (Lys14, Lys20, Lys21, Lys22, Lys25, Arg26, Lys28 and Arg29)
in T25-PBP A1ΔGT-TP were replaced with alanine prior to screening against
GpsB-T18. The pSH437 plasmid was mutated by Quikchange mutagenesis using
the primer pairs SHW744/SHW754 (T7A, pSH485), SHW746/SHW747 (R8A,
pSH486), SHW755/SHW756 (Y11A, pSH487), SHW748/SHW749 (R12A,
pSH488), SHW757/SHW758 (K14A, pSH489), SHW759/SHW760 (K20A,
pSH490), SHW761/SHW762 (K21A, pSH491), SHW763/SHW764 (K22A,
pSH492), SHW765/SHW766 (K25A, pSH493), SHW767/SHW768 (R26A,
pSH494), SHW769/SHW770 (K28A, pSH495) and SHW771/SHW772 (R29A,
pSH496).
pJR164 and pJR169 were constructed by cloning sepF (primers JR334/JR335
and XbaI/KpnI digestion) into pKT25 and p25-N, respectively. pJR165 and pJR170
were generated by cloning ezrA into pKT25 and p25-N, respectively, using primers
JR339/JR340 and XbaI/KpnI for digestion. pJR172 and pJR174 were obtained by
cloning zapA into pKT25 and p25-N, respectively, using primers JR337/JR338 and
PstI/KpnI. pJR213 was constructed by amplification of divIB with primers JR353/
JR354 and cloning into pKT25 using XbaI/KpnI. pJR214 was generated by PCR
amplification of divIC with primers JR355/JR356 and cloning into pKT25 using
XbaI/KpnI. mreBH was amplified by PCR using oligonucleotides JR368/JR369 and
cloned into pKT25 and p25-N using XbaI/KpnI, resulting in pJR233 and pJR236,
respectively. pJR242 and pJR243 were obtained by cloning mreC into pKT25 and
p25-N, respectively, using primers JR364/JR365 and PstI/KpnI digestion. pbpA2
was cloned into pKT25 using oligonucleotides SHW153/SHW154 and XbaI/KpnI
to create pJR250. pbpB1 was amplified with primers SHW157/SHW158 and cloned
with SmaI/EcoRI into pKT25, yielding pSH236. pbpB2 was amplified with primers
SHW155/SHW156 and cloned into pKT25 after PstI/BamHI digestion, yielding
plasmid pSH235. pbpB3 was amplified using primers SHW159/160 and cloned by
PstI/BamHI digestion into pKT25, resulting in pSH237. Finally, pSH484 was
obtained by removing the N-terminal domain from gpsB present on plasmid
pSH226 in a PCR with the primer pair SHW752/SHW753.
Plasmids encoding the respective genes fused to the N- or C-termini of the T18- or
the T25-fragment of the Bordetella pertussis adenylate cyclase were co-transformed
into E. coli BTH101. Transformants were selected on LB agar plates containing
ampicillin (100 µg−1mL−1), kanamycin (50 µg−1mL−1), X-Gal (40 µg−1mL−1) and
IPTG (0.1mM) and photographs were taken after 24 and 48h growth at 30 °C. The
BACTH experiments in Fig. 2b and Supplementary Figure 3C, D were repeated at
least twice.
The same procedures outlined above were followed for the BACTH using B.
subtilis GpsB except that co-transformants were grown on nutrient agar plates11,
not LB, before imaging. These experiments were replicated reproducibly at least
three times and a representative image is provided in Fig. 3c. Reciprocal tests for
some interactions do not show the same results presumably because of the different
expression levels for the individual fusion constructs as pKT25 is a low copy
number plasmid whereas pUT18C is a high copy number plasmid.
S. pneumoniae strain construction. Mutant strains containing antibiotic resis-
tance markers were constructed by transformation of CSP-1 induced competent
pneumococcal cells with linear DNA amplicons synthesised by overlapping fusion
PCR64. Mutant constructs were confirmed by PCR and DNA sequencing of
chromosomal regions corresponding to the amplicon region used for
transformation.
Ectopic expression of wildtype gpsB with a Zn2+-inducible promoter (IU11286)
was achieved by insertion into bgaA to create a ΔbgaA::tet-PZn-gpsB+ construct
using PCR-fused fragments. To investigate whether GpsB with allele changes of
Y23A, V28A, D29A L32A D33A or I36A were functional, and given that gpsB is
essential for the growth of S. pneumoniae D39, a merodiploid D39 Δcps
ΔgpsB<>aad9//ΔbgaA::PZn-gpsB+ strain (IU11388) was constructed by
transforming ΔgpsB<>aad9 into IU11286 in the presence of 0.5 mM ZnCl2+ 0.05
mM MnSO4, which is required in the media to counteract the Zn2+ toxicity57,64.
For selection of gpsB alleles, a Pc-erm cassette was fused to the 3ʹ end of gpsB with
the desired mutations in the native chromosomal locus. The gpsB allele change-Pc-
erm amplicon was transformed into IU11388 in the presence of erythromycin and
0.5 mM ZnCl2+ 0.05 mM MnSO4. The Pc-erm cassette inserted at the 3ʹ end of
gpsB+ imparted no discernible growth phenotype compared to a wild-type strain
(Fig. 5b). The growth of merodiploid strain IU11388, and strains containing gpsB
with allele changes complemented with ectopic expression of WT gpsB (IU12361,
IU12363, IU12440, IU12612, IU12615, IU13121), or gpsB with allele changes linked
to a FLAG tag complemented with ectopic expression of WT gpsB (IU13141,
IU13364, IU13366, IU13368, IU13370, IU13372 and IU13374) were performed in
the presence of 0.5 mM ZnCl2+ 0.05 mM MnSO4. Transformation of Δpbp1a::
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Pc-erm into IU11388 (ΔgpsB<>aad9//ΔbgaA::tet-PZn-gpsB+) and IU14365 (Δpbp2a
markerless//ΔbgaA::kan-PZn-pbp2a+) was performed in the presence of 0.4 mM
ZnCl2+ 0.04mM MnSO4. Strains containing markerless pbp2a alleles in the native
chromosomal locus were constructed using Janus cassette allele replacement65 via
an rpsL1 strain containing a Δpbp2a::Pc-[kan-rpsL+] construct (IU7853).
Transformation of a Δpbp1a amplicon into S. pneumoniae strains. The function
of the mutated pbp2a alleles was evaluated by transformations of 30 ng of a
Δpbp1a::Pc-erm amplicon, obtained from strain E177 and containing ≈1 kb of
flanking chromosomal DNA, into strains harbouring pbp2a mutations. Transfor-
mants were visualised after 24h incubation at 37 °C in 5% CO2. The numbers of
colonies were normalised to 1 mL of transformation mixture.
Growth and microscopy of S. pneumoniae strains. Strains IU1945 (wild-type
parent) and IU11286 (gpsB+//ΔbgaA::PZn-gpsB+) were inoculated from frozen
glycerol stocks into BHI broth, serially diluted, and incubated for <13h statically at
37 °C in an atmosphere of 5% CO2. For IU11388 (ΔgpsB//ΔbgaA::PZn-gpsB+) and
all gpsB allele exchange strains complemented with bgaA::PZn-gpsB+, 0.5 mM
ZnCl2+ 0.05 mM MnSO4 (+Zn) was added to BHI broth cultures to enable the
ectopic expression of gpsB64. The next day, cultures at OD620 ≈ 0.1–0.4 were diluted
to OD620 ≈ 0.003 in BHI broth lacking (−Zn) or containing (+Zn) 0.5 mM ZnCl2
+ 0.05 mM MnSO4 and cultured under the same conditions. Growth was mon-
itored turbidimetrically every 45 min to 1 h with a Genesys 2 spectrophotometer
(Thermo Scientific). At 3.75 h after dilution into BHI broth with or without Zn/Mn
supplement, cell pellets were obtained from 1mL of culture, and resuspended in
100 µL of 4% paraformaldehyde. Cells were fixed for 15 min at RT and the tubes
with fixed cells were left on ice until microscopy. For microscopic analyses, samples
(1.5 μL) were taken and examined using a Nikon E-400 epifluorescence phase-
contrast microscope. Growth and microscopy of strains containing pbp2a alleles
were performed as above, but with no Zn/Mn addition to the BHI broth. Micro-
scopy was performed at OD620 ≈ 0.15.
Growth and microscopy experiments of IU14381 (Δpbp2a//PZn-pbp2a+
Δpbp1a) and IU14383 (ΔgpsB//PZn-gpsB+ Δpbp1a) were performed as for IU11388
(ΔgpsB//PZn-gpsB+) except that overnight growths were carried out in BHI broth
containing 0.2 mM ZnCl2+ 0.02 mM MnSO4 for IU14381, and 0.4 mM ZnCl2+
0.04 mM MnSO4 for IU14383. Cultures were diluted into the same media as the
overnight media for +Zn condition and into BHI broth without Zn/Mn for the
−Zn condition. All growth measurements were reproducible and were repeated at
least three times. The mean doubling time and the standard error of the mean ( ± )
are reported in Supplementary Figure 5B.
Western blotting and immunodetection of S. pneumoniae strains. To confirm
the expression of gpsB with Y23A, V28A, D29A, L32A, D33A or I36A allele
exchanges, western blot analyses were performed of strains constructed with gpsB-
FLAG or gpsB variant-FLAG at the native site complemented by ectopic Zn-
dependent expression of WT gpsB. 0.5 mM ZnCl2+ 0.05 mM MnSO4 (+Zn) was
added to all BHI broth cultures to enable the ectopic expression of gpsB, and were
diluted to OD620 ≈ 0.003 and cultured under the same conditions to OD620 ≈ 0.15
to 0.2. Under the +Zn condition, all FLAG-tagged gpsB allele exchange strains
grew identically to WT gpsB+ strain and to the untagged gpsB allele exchange
strains. A parallel set of cultures was performed using BHI broth without addition
of ZnCl2 and MnSO4 to confirm that FLAG-tagged gpsB allele strains grew iden-
tically to their untagged counterparts. Aliquots of 1.8 mL were centrifuged (5 min,
16,000 × g at 4 °C), and cell pellets were washed once with PBS. The supernatant
was discarded and the pellets were frozen on dry ice for 5 min. The pellets were
then thawed for 5 min at RT, resuspended in 80 µL of prewarmed 37 °C SEDS lysis
buffer (0.1% deoxycholate, 150 mM NaCl, 0.2% SDS, 15 mM EDTA pH 8.0)24.
Samples were incubated on a 37 °C shaking block at 300 rpm for 15 min, and were
vortexed vigorously twice during the 15 min incubation. Total protein concentra-
tions were determined using a Bio-Rad DCTM protein assay kit. 4 µg of total
protein was loaded per lane on a 4–15% precast gradient SDS-PAGE gel (Bio-Rad),
subjected to electrophoresis and transferred to a nitrocellulose membrane. FLAG-
tagged GpsB proteins were detected with an anti‐FLAG rabbit polyclonal antibody
(Sigma, F7425, 1:1400 dilution) as primary antibodies, and ECL anti-rabbit IgG
horseradish peroxidase linked whole antibody as secondary (dilution 1:10,000).
Chemiluminescent signals in protein bands were detected with an IVIS imaging
system. MreC was detected with anti-MreC antibodies66 by relabelling the nitro-
cellulose membrane after detection with anti-FLAG.
Western detection of PBP2a in various PBP2a variant strains was performed
essentially as above with exponentially growing cultures in BHI broth. 4 µg of total
protein was loaded per lane onto a 10% precast SDS-PAGE gel (Bio-Rad).
Electrophoresis was carried out for 1.5 h to allow separation of SpPBP2a from a
non-specific band. Anti-SpPBP2a serum67 was used at a dilution of 1:5000.
The anti-serum against purified, recombinant SpGpsB1-63 was characterised by
preparing lysates from gpsB+ divIVA+ WT (strain IU1945), ΔgpsB (IU6442) or
ΔdivIVA (IU8496) strains as described above. 4 μg of total protein was loaded per
lane on a 4–20% precast gradient SDS-PAGE gel (Bio-Rad), and anti-GpsB serum
from rabbit Ab-1432 was used at a dilution of 1:2000.
Co-immunoprecipitation (Co-IP) of S. pneumoniae strains. Co-IP experiments
of S. pneumoniae FLAG-tagged strains were performed with the use of anti-FLAG
magnetic beads24. Lysates were obtained from cultures grown exponentially at
37 °C in an atmosphere of 5% CO2 in 400 mL of BHI to OD620 ≈ 0.25–0.4024. Cell
pellets were washed once with 30 mL of 1X PBS (4 °C) and resuspended in 19.8 mL
1× PBS (4 °C). About 200 μL of 10% (vol per vol) paraformaldehyde solution
(EMS) were added for crosslinking to a final concentration of 0.1% (vol per vol).
Mixtures were incubated at 37 °C in an air incubator for 1 h. Cross‐linking reac-
tions were quenched by the addition of 4 mL 1.0 M glycine followed by incubation
at 25 °C for 10 min. Cells were collected by centrifugation (16,500 × g for 5 min at
4 °C). Pellets were washed once with 20 mL cold 1× PBS (4 °C) and resuspended in
2 mL of cold lysis buffer (50 mM Tris‐HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1%
Triton X100 (vol per vol)) with 1 tablet of protease inhibitor (ThermoFisher Sci-
entific, 78429) freshly added per 10 mL of lysis buffer. The suspension was
transferred into two lysing matrix B tubes (MP Biomedicals) with 1 mL in each
tube. The tubes were shaken ten times in a FastPrep homogenizer (4×, 5 min on
ice, 3×, 5 min on ice and 3×) with 6.0 M s−1 for 40 s each at 4 °C. Cell debris and
lysing matrix from tubes were removed by centrifugation at 16,000 × g for 5 min at
4°C. The protein concentration of each sample was determined by Bio‐Rad DCTM
protein assay (Bio‐Rad). About 1 mL of lysate with similar amounts of total protein
(5–7 mg−1mL−1) was added to tubes with 50 μL of anti‐FLAG magnetic beads
(Sigma, M8823). The same amount of protein was loaded onto the beads for strains
expressing FLAG‐tagged proteins and the corresponding control strains lacking
FLAG‐tagged proteins in each experiment. The tubes were rotated for 2 h at 4 °C.
The beads were washed three times with 1 mL of lysis buffer (4 °C) with 10 min
incubation at 4 °C each time. FLAG‐tagged proteins were eluted from the beads by
incubation with 100 μL of FLAG elution solution (150 ng 3X FLAG peptide per μL)
(Sigma, F4799) for 30 min at 4 °C. A volume of 100 μL of the elution and of the
original lysate added to magnetic beads (input) were separately mixed with 100 μL
2× Laemmli sample buffer (Bio‐Rad) containing 5% (vol per vol) β‐mercap-
toethanol (Sigma) and heated at 95 °C for 1 h to break the cross‐links. A volume of
40 µL of each elution sample mixed with 2× sample buffer was loaded on each lane
of a 4–15% precast SDS-PAGE gel and subjected to western blotting using affinity-
purified SpPBP2x polyclonal antibodies (dilution 1:10,000)67 or an anti-GpsB
antibody as the primary antibodies.
S. pneumoniae BACTH assay. The target genes were amplified by the PCR from S.
pneumoniae D39 chromosomal DNA. PCR fragments for pbp2a, mreC, pbp1a,
pbp2x and pbp2b were purified, digested with appropriate restriction enzymes and
cloned into the corresponding sites of the pKT25/pUT18C vectors to generate
plasmids encoding the corresponding hybrid proteins fused at the C-terminal ends
of the T25 and T18 fragments, respectively. Plasmids pKNT25-gpsB/pUT18-gpsB,
pKNT25-stkP/pUT18-stkP and pKNT25-ezrA/pUT18-ezrA were already con-
structed24. The mutated and truncated gpsB and pbp2a alleles were amplified from
their respective DNA templates and the corresponding PCR products cloned into
the corresponding sites of the BACTH vectors as described above for the wild-type
alleles. E. coli DH5α transformants were selected on LB agar plates containing
ampicillin (100 μg−1mL−1) or kanamycin (50 μg−1mL−1) and 0.4% glucose to
repress leaky expression63.
BACTH experiments, each pair of plasmids was co-transformed into the E. coli
cya- strain BTH101 and co-transformation mixtures were spotted onto LB agar
plates supplemented with ampicillin (100 mg−1mL−1), kanamycin (50 mg−1mL−1)
and X-Gal (40 μg−1mL−1), followed by incubation at 30 °C. Plates were inspected
and photographed after 24 and 40 h. Plasmid pairs pKNT25/pUT18 and pKT25-
zip/pUT18C-zip were used as negative and positive controls, respectively. All
experiments were repeated at least twice.
Plasmid construction for recombinant protein and peptide work. (i) GpsB: All
mutagenesis was undertaken by the Quikchange protocol; where mutagenesis
reactions failed to generate a DNA fragment of the expected size, a modification of
the Quikchange protocol with two separate PCR steps was used instead69.
Glu17Ala, Asp31Ala and Asp35Ala mutations were introduced to the BsGpsB1-68
expression construct plasmid19 by Quikchange. The BsGpsB5-64 construct was
prepared by PCR amplification of gpsB from B. subtilis 168 genomic DNA using
primers BsGpsB5start and BsGpsB64stop. The PCR product was ligated between
the NdeI and XhoI sites of modified pET15b (M26L DJ-1 TEV site pET15b; gift
from Mark Wilson, Addgene) with the nucleotides encoding the thrombin cleavage
site replaced by a sequence encoding a TEV cleavage site. The SpGpsB1-63
expression construct (pET28SpGpsB1-63) was prepared by PCR amplification of
gpsB from S. pneumoniae R6 genomic DNA with primers SpGpsB5ndeI and
SpGpsB3XhoI. This PCR product was ligated between the NdeI and XhoI sites of
pET28a, and a stop codon was introduced by Quikchange mutagenesis in place of
the codon for Pro64. The SpGpsB4-63 expression construct was generated in two
steps; first the ORF encoding residues 1–63 of SpGpsB was amplified with primers
SpGpsBM11NcoI and SpGpsBM11XhoI using plasmid pET28SpGpsB1-63 as the
template. This DNA fragment was then ligated between the NcoI and XhoI sites of
pET11M70 before the codons for residues 1–3 of SpGpsB were deleted by Quik-
change mutagenesis with primers SpGpsB1to3del5 and SpGpsB1to3del3.
(ii) PBP peptides; Ser16Cys, Ser7Ala, Arg8Ala, Ala10Pro, Arg11Ala and
Arg28Ala mutations in BsPBP11-32 fused to maltose binding protein (MBP)19 were
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introduced by Quikchange mutagenesis. Plasmids expressing LmPBPA11-20 and
SpPBP2a23-45 peptides fused to MBP were prepared by PCR amplifying the relevant
ORFs from L. monocytogenes strain EGD-e and S. pneumoniae R6 genomic DNA
with primers LmPBPA1ncoI5, LmPBPA1xhoI3, SpPBP2AncoI5 and
SpPBP2AxhoI3, respectively. The subsequent PCR fragments were digested with
NcoI and XhoI for ligating into similarly restricted pMAT11, a modified version of
pHAT470. Ser19 and Lys21 in LmPBPA1 were mutated in a single step by
Quikchange to cysteine and stop codons, respectively; similarly Quikchange was
used to change SpPBP2a Gly43 and Arg46 to cysteine and stop codons,
respectively. Further mutations in LmPBPA1 were also made by Quikchange; the
Arg8AlaSer16Arg double mutant was prepared in two successive steps with the
Arg8Ala mutation made first, followed by Ser16Arg.
The SpPBP2x1-29 construct was prepared in several steps. First, nucleotides
1–1165 of pbp2x were PCR amplified in two steps: an initial fragment generated
from S. pneumoniae R6 genomic DNA with primers SpPBP2x5/SpPBP2x3st1 was
used as a template for further PCR amplification with SpPBP2x5/SpPBP2x3st2
primers; this fragment was then ligated into the NcoI and XhoI sites of pMAT11.
Second, cysteine, serine and stop codons were introduced by Quikchange in place
of residues 30–32 with primers SpPBP2xS30CL31SL32STOP5 and
SpPBP2xS30CL31SL32STOP3. A second Quikchange step (primers
SpPBP2xinsgly5, SpPBP2xinsgly3) introduced extra codons encoding a GSG
sequence after the TEV cleavage to improve cleavage of the MBP-PBP2x1-29 fusion
protein.
(iii) YpbE and YrrS; The construct for expressing YpbE130-240 was prepared in
two steps; first, the ORF encoding residues 80-240 of YpbE was PCR amplified
from genomic DNA and ligated between the NdeI and XhoI sites of pET28a.
Second, the ORF encoding the N-terminal His-tag and residues 80–129 of YpbE
was subsequently deleted by PCR amplification of the entire plasmid with primers
YpbEtruncatencoi5 and YpbEtruncatencoi3, followed by NcoI restriction digestion
and religation of the DNA with T4 DNA ligase. The construct for expressing
YrrSΔ13-16 was prepared by amplifying the yrrS gene from B. subtilis genomic DNA
with flanking NdeI and XhoI sites and then ligating the PCR fragment between the
same restriction sites in pET28a. The region coding for residues 13–16 of YrrS was
subsequently deleted by Quikchange mutagenesis.
Recombinant protein purification. (i) GpsB; BsGpsB1-68 proteins used for FP
assays were purified by Ni-NTA affinity chromatography followed by proteolytic
removal of the His6-tag by thrombin and subsequent size exclusion chromato-
graphy19. The same protocol was used for SpGpsB1-63 except that an ammonium
sulphate precipitation step was added after thrombin removal of the His6-tag.
Ammonium sulphate was added to the thrombin-cleaved protein to a final con-
centration of 2.34 M (60% saturation at 0 °C) by adding a stock solution of 100%
saturated ammonium sulphate that was prepared by adding solid ammonium
sulphate directly to 50 mM Tris.HCl (pH 8), 300 mM NaCl, 10 mM imidazole.
After stirring for 30 min at 4 °C the mixture was centrifuged at 19,000 × g for 20
min and solid ammonium sulphate then added to the supernatant to a final
concentration of 2.8 M. After stirring at 4 °C for another 30 min the mixture was
again centrifuged 19,000 × g for 20 min and further ammonium sulphate added to a
final concentration of 3.5 M. After 30 min stirring the mixture was again cen-
trifuged at 19,000 × g and the pellet resuspended in 10 mM Tris.HCl (pH 8), 250
mM NaCl before further purification by gel filtration19. BsGpsB5-64, BsGpsB5-
64
Lys32Glu and SpGpsB4-63 were expressed and purified by a similar protocol except
that TEV protease, rather than thrombin, was used to remove the N-terminal His6-
tag by overnight cleavage with TEV (1:50 ratio of TEV:GpsB) at 4 °C in a buffer of
50 mM Tris.HCl (pH 8.0), 300 mM NaCl, 250 mM imidazole, 1 mM DTT. The
cleaved protein was then dialysed against 20 mM Tris.HCl (pH 8.0), 200 mM NaCl,
10 mM imidazole and manually passed over a 5 mL Ni-NTA superflow cartridge
(Qiagen) to remove TEV and uncleaved proteins. The flow through from the
column was concentrated and loaded onto a Superdex 75 XK16/60 (GE Health-
care) gel filtration column equilibrated in 10 mM HEPES.NaOH (pH 8.0), 100 mM
NaCl.
(ii) PBP peptides; The PBP peptides, generated as His-tagged MBP-fusion
proteins, were purified by standard Ni-NTA affinity chromatography procedures19.
The purified MBP-PBP fusions at 5 mg−1mL−1 were fluorescently labelled in a
buffer of 50 mM Tris.HCl (pH 7.0), 300 mM NaCl, 250 mM imidazole by mixing
with either TAMRA-maleimide (Santa Cruz Biotechnology) or with fluorescein
maleimide (Vector laboratories) to final concentrations of 625 μM and 1mM from
25 and 40 mM stocks made in DMSO, respectively. After overnight incubation at 4
°C the labelling reaction was exchanged into a buffer of 10 mM Tris.HCl (pH 8.0),
250 mM NaCl, cleaved with TEV protease (1:50) and the labelled peptide separated
from the MBP fusion partner by passing through a 3 kDa molecular mass cutoff
centrifugal ultrafiltration device19.
The BsPBP11-17, LmPBPA11-15 and SpPBP2a27-40 peptides used for
crystallisation and circular dichroism were synthesised chemically (Protein and
Peptide Research Ltd, UK and Severn Biotech, UK). The fluorescein-labelled
BsYpbE1-21 and SpPBP2b1-17 peptides used in FP assays were also synthesised
chemically (Protein and Peptide Research Ltd); the SpPBP2b1-17 peptide
encompasses the first seventeen amino acids of SpPBP2b from strain R6, based on
the annotated sequence in the NCBI database (accession NP_359110).
(iii) BsPBP1 proteins; Recombinant BsPBP1 proteins were purified from E. coli
membrane pellets19 resuspended in a buffer of 50 mM HEPES.NaOH pH 7.5, 500
mM NaCl, 3 mM MgCl2, 0.3 mM DTT supplemented with Roche complete EDTA-
free protease inhibitor cocktail, lysozyme and DNAase. The lysate was clarified by
centrifugation at 10,000 × g for 20 min and the supernatant centrifuged further for
1 h at 4 °C at 100,000 × g. The membrane pellet was resuspended in lysis buffer
supplemented with 15% glycerol, 0.2 mM AEBSF, 0.5 mM DTT and Roche
complete EDTA-free protease inhibitor. The resuspended membranes were
ultracentrifuged for 1 h at 4 °C at 100,000 × g and the membrane pellet resuspended
in resuspension buffer (50 mM HEPES.NaOH pH 7.5, 500 mM NaCl, 3 mM
MgCl2, 2% reduced Triton X-100, 15% glycerol, 10 mM β-mercaptoethanol). After
2 h stirring at 4 °C the extract was ultracentrifuged at 100,000 × g for 30 min at 4 °C.
The supernatant was supplemented with imidazole to 5 mM then incubated for 2 h
at 4 °C with Sigma His select resin. This mixture was then passed through a gravity
column and the resin washed with resuspension buffer supplemented with 5 mM
imidazole and then BsPBP1 proteins were eluted with resuspension buffer
containing 250 mM imidazole. The His6-tag was removed by thrombin treatment,
before the digest was purified by Superdex S200 size exclusion chromatography in a
buffer of 10 mM HEPES.NaOH pH 7.5, 500 mM NaCl, 3 mM MgCl2, 0.1% reduced
Triton X-100, 2% glycerol. Residual uncleaved BsPBP1 proteins were removed by
incubation with His select resin before concentraing and snap-freezing in liquid
nitrogen.
(iv) YpbE; The YpbE130-240 protein and its S132C variant were expressed in
BL21(DE3) cells by induction overnight at 17 °C with 0.5 mM IPTG when the
culture had reached an optical density at 600 nm of 0.6. The cell pellet from a 2 L
culture was resuspended in 70 mL of 50 mM Tris.HCl (pH 8), 10 mM NaCl,
supplemented with 1 mL of 25× working concentration of Roche Complete EDTA
free protease inhibitor cocktail and lysed by sonication. The lysate was then passed
over a XK16 column packed with a 25 mL bed volume of Fast Flow Q-Sepharose
and the flow through from the column then mixed with an equal volume of lysis
buffer supplemented with saturated ammonium sulphate at room temperature.
After 30 min stirring at 4 °C the mixture was centrifuged at 19,000 × g for 20 min
and the supernatant mixed with saturated ammonium sulphate to a final
concentration of 60%. This mixture was stirred for 30 min at 4 °C then centrifuged
for 20 min at 19,000 × g. The supernatant was mixed further with ammonium
sulphate to a final concentration of 80%. After 30 min stirring at 4 °C the mixture
was centrifuged for 30 min at 19,000 × g then the pellet resuspended in 5 mL 10
mM MES buffer pH 6. The resuspended pellet was then loaded onto a 5 mL Fast
Flow HiTrap SP column (GE Healthcare) equilibrated in 25 mM MES.NaOH pH 6
and the protein eluted with a linear gradient of 0–500 mM NaCl. Fractions
containing YpbE130-240 were pooled, concentrated and loaded onto a Superdex 75
XK16/60 gel filtration column (GE Healthcare) pre-equilibrated in PBS.
(v) YrrS; YrrSΔ13-16 was expressed in BL21(DE3) cells by overnight induction at
20 °C with 0.4 mM IPTG. The pellet from a 2 L culture was resuspended in 25mL
50mM Tris.HCl (pH 8), 500mM NaCl supplemented with 0.5mg−1mL−1
lysozyme, 2 µg−1mL−1 DNAase and Roche Complete protease inhibitor cocktail.
The cell suspension was lysed by sonication, and centrifuged at 10,000 × g for 20
min at 4 °C to remove intact cells. The supernatant was centrifuged at 100,000 × g at
4 °C for 1 h and the membrane pellet was resuspended in 15mL 50mM Tris.HCl
(pH 8), 500mM NaCl 10% (vol per vol) glycerol and centrifuged again for 1 hr at
100,000 × g at 4 °C. The membrane pellet was frozen in liquid nitrogen and stored at
−80 °C. The membrane pellet was resuspended in 10mL of 50mM Tris.HCl (pH
8), 500mM NaCl, 2% reduced Triton X-100, 5 mM imidazole supplemented with
Roche Complete EDTA free protease inhibitor cocktail. After 3 h gentle agitation at
4 °C the membrane suspension was centrifuged at 4 °C at 100,000 × g for 30 min. A
0.4 mL bed volume of Ni-NTA Sepharose (Qiagen) was added to the supernatant
and mixed overnight at 4 °C in a tube roller before filtering through an empty
gravity column. The Ni-NTA beads were washed three times with 4mL of 50mM
Tris.HCl (pH 8), 500mM NaCl, 0.1% reduced Triton X-100, 5 mM imidazole and
YrrSΔ13-16 was eluted from the column with 4mL of the same buffer supplemented
with 250mM imidazole. The eluate was concentrated to 0.5 mL and loaded onto a
Superdex 200 HR10/300 gel filtration column (GE Healthcare) equilibrated in 10
mM Tris.HCl (pH 8), 250mM NaCl, 0.1% reduced Triton X-100.
All recombinant proteins or peptides were concentrated and flash frozen in
small aliquots in liquid nitrogen and stored at −80 °C.
Crystallisation and structure determination. Successful crystallisation of the N-
terminal domains of GpsB proteins was improved by truncation of a few amino
acids from both N- and C-termini, which are too far from the PBP binding site (25
and 45 Å, respectively) to affect binding and correspond to the minimum ordered
portion of GpsB19. Co-crystallisation of BsGpsB5-64:BsPBP11-17, BsGpsB5-64Lys32Glu:
LmPBPA11-15 and SpGpsB4-63:SpPBP2a27-40 followed the same procedure. Equal
volumes of GpsB protein and PBP peptide, both in a buffer of 10mM HEPES.
NaOH (pH 8.0) and 100mM NaCl, were mixed at final concentrations of 20 and 25
mg−1 mL−1, respectively. This mixture, corresponding to a 1:5 molar ratio of
protein:peptide, was subjected to sparse matrix crystallisation screening at room
temperature with 100 nL drops dispensed by a Mosquito (TTP Labtech) liquid
handling robot into 96 well MRC crystallisation plates. Unbound SpGpsB4-63 was
crystallised by the same procedure, at the same protein concentration, except for the
absence of added peptide. Crystals of BsGpsB5-64:BsPBP11-17 grew from 0.1M
HEPES/MOPS pH 7.5, 12.5% MPD, 12.5% PEG 1000 12.5% PEG 3350, 0.03M
MgCl2, 0.03M CaCl2 and were mounted in rayon loops and frozen directly in liquid
nitrogen. Crystals of BsGpsB5-64Lys32Glu:LmPBPA11-15 grew from 0.1M imidazole
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pH 8, 0.2M zinc acetate, 20% PEG 3000 were transferred to a cryoprotectant
comprising the well solution supplemented with 20% vol per vol PEG 300 and
2.5mg−1 mL−1 of the LmPBPA11-15 peptide; after 3 min the crystals were mounted
in rayon loops and frozen in liquid nitrogen. The SpGpsB4-63:SpPBP2a27-40 complex
crystallised in 0.1M Tris.HCl pH 8.5, 0.2M lithium sulphate, 40% PEG400;
crystals were mounted after 1 μL of the crystallisation mother liquor containing
2.5mg−1mL−1 SpPBP2a27-40 peptide was layered over the crystallisation drop
immediately prior to freezing directly in liquid nitrogen. Crystals of unbound
SpGpsB4-63 were obtained from 0.1M Tris.HCl pH 8.5, 0.2M magnesium chloride,
20% PEG 8000 and were cryoprotected by direct transfer to a solution of the mother
liquor supplemented with 20% PEG400 before mounting and freezing as above.
X-ray data were collected from crystals of unbound SpGpsB4-63 in house with a
galliumMETALJETTM (Bruker AXS GmbH) as X-ray source at a wavelength of 1.34
Å. All other diffraction data were collected at the DIAMOND synchrotron: for
BsGpsB5-64:BsPBP11-17 data were collected on beamline I24 at a wavelength of
0.9686 Å; for BsGpsB5-64Lys32Glu:LmPBPA11-15 data were collected on beamline
I04 at a wavelength of 0.9795 Å and for SpGpsB4-63:SpPBP2a27-40 data were collected
on beamline I03 at a wavelength of 0.9762 Å. For BsGpsB5-64:BsPBP11-17 and
SpGpsB4-63:SpPBP2a27-40 the diffraction images were indexed and integrated with
XDS71 and scaled with AIMLESS72. For BsGpsB5-64Lys32Glu:LmPBPA11-15 the
diffraction images were indexed and integrated with DIALS73, scaled in XDS71 and
merged with AIMLESS72. For unbound SpGpsB4-63 the images were indexed,
integrated, scaled and merged in Proteum 3 (Bruker AXS GmbH). For the three
different GpsB:PBP complexes and the unbound SpGpsB4-63 the initial phases were
obtained by molecular replacement (MR) in PHASER74. For BsGpsB5-64:BsPBP11-17
residues 5-64 from the structure of dimeric GpsB1-68 (PDBid 4UG319) were used as
the search model for MR whereas for BsGpsB5-64Lys32Glu:LmPBPA11-15 the MR
search model was the co-ordinates of the BsGpsB5-64:BsPBP11-17 complex with the
peptide removed. For the unbound SpGpsB4-63 the search model for MR was the N-
terminal domain of LmGpsB (PDB code 4UG119). For the SpGpsB4-63:SpPBP2a27-40
complex, the co-ordinates of the unbound SpGpsB4-63 protein were used as a search
model for MR. In all cases the molecular replacement solutions were visualised and
rebuilt in COOT75. The BsGpsB5-64Lys32Glu:LmPBPA11-15 and SpGpsB4-63:
SpPBP2a27-40 complexes were refined in PHENIX.REFINE76 while the BsGpsB5-64:
BsPBP11-17 complex and unbound SpGpsB4-63 were refined using REFMAC77. The
Ramachandran plot statistics (favoured/allowed) are: BsGpsB5-64:BsPBP11-17 100%/
0%; BsGpsB5-64Lys32Glu:LmPBPA11-15 99.2%/0.8%; SpGpsB4-63:SpPBP2a27-40 98.6%/
1.4%, and unbound SpGpsB4-63 99.6%/0.4% allowed. Statistics for data collection and
for the final refined models can be found in Table 1. Representative electron density
maps for the peptide-bound structures are displayed in stereographic mode in
Supplementary Figure 8.
FP assays. FP experiments were undertaken in a buffer of 10mM Tris.HCl (pH
8.0), 250mM NaCl, 0.1% reduced Triton X-100. The excitation wavelength was 540
nm and fluorescence emission was recorded above 590 nm for TAMRA-labelled
peptides. The N-terminal domains of GpsB proteins BsGpsB1-68, LmGpsB1-73,
SpGpsB1-63 were used in all experiments in preference to the full-length GpsB
proteins due to the high solubility of the former, which facilitated achieving the high
protein concentrations necessary to saturate peptide binding. The validity of the N-
terminal domain as a substitute for full-length GpsB proteins in these experiments is
supported by the comparable affinity of BsGpsB and BsGpsB1-68 for a labelled
BsPBP1A1-32 peptide in FP experiments (Supplementary Table 1). Kd values ± the
standard error, generated after simultaneously fitting all the binding data to a 1:1
interaction model are reported and there are three measurements at each data point
in a titration.
SPR. All SPR experiments used a running buffer of 10 mM Tris.HCl (pH 8.0), 250
mM NaCl, 0.1% reduced Triton X-100. BsPBP1 and BsPBP117-914 were immobi-
lised on the surface of a CM5 chip (GE Healthcare). For the BsPBP1/YrrSΔ13-16
titration 800 RUs of BsPBP1 were immobilised on the chip surface; for the BsPBP1/
BsGpsB titration 1200 RUs of BsPBP1 were immobilised. YrrSΔ13-16, which lacks
residues 13–16 in the cytoplasmic domain, was used in these experiments to
minimise non-specific interactions with the chip matrix; binding of YrrSΔ13-16 to
the reference surface was negligible and the deletion of residues 13–16 leaves the
GpsB-binding motif intact. The YrrSΔ13-16 titration was carried out in single-cycle
mode, without regenerating the surface between successive injections of protein,
because harsh reagents were necessary for full surface regeneration. The fit of the
single-cycle mode data to a 1:1 binding model was achieved with a U-value of 2 and
a corresponding χ2 of 46.1.
CD analysis. CD spectra were recorded on a JASCO J-810 spectropolarimeter with a
PTC-4235 Peltier temperature controller using 1mm path length quartz cuvettes. For
full wavelength scans a scan speed of 10 nm−1min−1 and a response time of 4 s were
used, the final spectra were the average of at least four measurements. BsPBP11-32 CD
spectra were recorded at 4 °C in a buffer of 20mM sodium phosphate, pH 7.3 at a
peptide concentration of 25 μM. Peptide helical contents were estimated from molar
ellipticities at 222 nm using the equation helix= [θ]222 nm / (39,500(1–2.57/n))78 where
Table 1 Data collection and refinement statistics
BsGpsB5-64:BsPBP11-17 BsGpsB5-64Lys32Glu:LmPBPA11-15 Unbound SpGpsB4-63 SpGpsB4-63:PBP2a27-40
Data collection
Space group P 21 21 21 P 1 21 1 P 1 21 1 C 1 2 1
a, b, c (Å) 31.5, 53.8, 85.9 26.6, 31.4, 81.0 39.1, 54.5, 61.6 83.1, 26.4, 65.9
α, β, γ (°) 90, 90, 90 90, 92.4, 90 90, 106.1, 90 90, 106.4, 90
Resolution (Å) 45.57–1.95 (2.00–1.95)a 31.42–1.60 (1.63–1.60)a 27.22–1.90 (1.94–1.90)a 39.85–1.80 (1.84–1.80)a
Rpim 0.059 (0.473) 0.044 (0.386) 0.041 (0.311) 0.051 (0.269)
CC (1/2) (%) 99.4 (72.0) 99.7 (74.3) 99.8 (78.0) 97.6 (88.3)
I/σI 8.8 (2.1) 8.4 (1.8) 13.9 (4.0) 9.0 (2.2)
Completeness (%) 100.0 (100.0) 99.8 (99.9) 100 (100) 99.8 (99.9)
No. of observations 78,385 (5459) 63,406 (3019) 497,944 (28,050) 46,904 (2454)
No. of unique reflections 11,206 (768) 17,944 (902) 19,776 (1353) 13,052 (763)
Redundancy 7.0 (7.1) 3.5 (3.3) 25.2 (20.7) 3.6 (3.2)
Refinement
Resolution (Å) 45.57–1.95 29.29–1.60 26.01–1.90 39.85–1.80
No. of reflections 11,162 17,912 19,738 13,007
Rwork/Rfree 0.187/0.214 0.173/0.204 0.188/0.249 0.178/0.225
No. of atoms
Protein 951 986 1919 999
Peptide 94 20 — 220
Ligand/ion 1 5/8 — 30/1
Water 48 106 260 87
B-factors (Å2)
Protein 34.0 25.2 24.8 18.7
Peptide 39.3 36.0 — 32.5
Ligand/ion 23.7 30.9/36.5 — 57.9/12.1
Water 36.4 35.6 30.6 28.1
R.m.s. deviations
Bonds (Å) 0.006 0.016 0.017 0.015
Angles (°) 0.673 1.372 1.399 1.393
aValues in parentheses refer to the highest resolution shell
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n is the number of residues in the peptide. LmPBPA11-15 CD spectra were analysed at
40 μM in 20mM sodium phosphate buffer, pH 7.8, for samples containing 0, 40 and
60% trifluoroethanol (TFE). For samples containing 80% TFE, 5mM sodium phos-
phate buffer, pH 7.8, was used. The CD spectra of BsGpsB1-68 proteins were measured
at a concentration of 4.5 μM in a buffer of 20mM sodium phosphate (pH 7.8)
150mM NaCl. For thermal melt experiments, a response time of 8 s and scan rate of
1 °C−1min−1 were used. All thermal melts were reversible as CD spectra recorded
before and after the melts in the wavelength range 200–240 nm could be
superimposed.
Peptidoglycan pulldown assay. PG pulldown assays were carried out in PBS
buffer. B. subtilis PG (SigmaAldrich) was prepared as a 10 mg−1 mL−1 stock
solution in PBS containing 0.02% sodium azide. 25 µg of protein were added to a
100 µL sample containing 66 µg of PG and the mixture incubated with gentle agi-
tation at room temperature for 30min. The mixture was centrifuged at 16,000 × g
for 7 min, the supernatant removed and the pellet resuspended in 1 mL of ice-cold
PBS and immediately centrifuged for 2 min at 16,000 × g. The pellet was resus-
pended in 1mL of the appropriate buffer and centrifuged for 2 min at 16,000 × g.
Finally the pellet was boiled for 3 min in 60 μL SDS-PAGE loading buffer before
analysis by SDS-PAGE; the SDS-PAGE loading buffer lacked reducing agents for
YpbE130-240Ser132Cys samples.
Data availability
The crystallographic data that support the findings of this study are available in
the PDB with the identifiers: 6GP7 for BsGpsB5-64:BsPBP11-17; 6GPZ for
BsGpsB5-64Lys32Glu:LmPBPA11-15; 6GQN for SpGpsB4-63:SpPBP2a27-40; and
6GQA for unbound SpGpsB4-63. All the other data that support the findings of
this study are available from the corresponding author upon request.
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